Dr. Taube is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Dept Pathology RM 401 Carnegie
Baltimore, MD 21287Phone+1 410-955-3980Fax+1 410-955-2445
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Dermatopathology, 2008 - 2009
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2008 - 2008
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2004 - 2007
- Tulane University School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2007 - Present
- MD State Medical License 2009 - 2025
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 895 citationsPD-1 Blockade in Tumors with Mismatch-Repair Deficiency.Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling
The New England Journal of Medicine. 2015-06-25 - 55 citationsPD-1, PD-L1, PD-L2 expression in the chordoma microenvironmentDimitrios Mathios, Jacob Ruzevick, Christopher M. Jackson, Haiying Xu, Sagar R. Shah
Journal of Neuro-Oncology. 2015-01-01 - 1854 citationsMechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapySuzanne L. Topalian, Janis M. Taube, Robert A. Anders, Drew M. Pardoll
Nature Reviews. Cancer. 2016-05-01
Journal Articles
- Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic MelanomaM T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology
Press Mentions
- Interrogating the Complexities of the Tumor MicroenvironmentMay 19th, 2023
- Combinatorial Biomarker Predicts Response to Immunotherapy in Renal Cancer PatientsApril 6th, 2023
- Researchers ID Biomarkers of Response to Immunotherapy for Kidney CancerApril 6th, 2023
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/janis-taube
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: